Effects of Mechanical, Chemical, and Combination Methods on Halitosis

NCT ID: NCT06890104

Last Updated: 2025-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-16

Study Completion Date

2024-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Goal:

The goal of this clinical trial is to evaluate the effectiveness of different oral hygiene methods (tooth brushing, tongue cleaning, and mouthwash use) in managing halitosis (bad breath) in adults. The main questions it aims to answer are:

Do oral hygiene methods (tongue cleaning, chlorhexidine mouthwash, and coconut oil mouthwash) reduce the levels of volatile sulfur compounds (VSCs) in participants' breath?

Do these methods improve self-reported and clinically assessed halitosis?

Study Design:

Researchers will compare three intervention groups:

Group I: Tongue cleaning. Group II: Chlorhexidine mouthwash. Group III: Coconut oil mouthwash.

After one week, Groups II and III will add tongue cleaning, and in the third week, Groups I and III will use chlorhexidine mouthwash to ensure equitable benefits.

Participants will:

Follow their assigned oral hygiene regimen daily for 2 weeks. Receive the halitosis assessments at baseline, 1 week, and 2 weeks post-intervention, including organoleptic testing and volatile sulfur compounds level measurements using the OralChroma device.

Complete self-reported assessments of halitosis using a visual analog scale (VAS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Halitosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tongue brushing

Group Type NO_INTERVENTION

No interventions assigned to this group

Mouthrinse with Chlorhexidine 0.12%

Group Type ACTIVE_COMPARATOR

Mouthrinse with Chlorhexidine 0.12%

Intervention Type OTHER

Using mouthrinse with 0.12% chlorhexidine for two weeks to treat halitosis

Mouthrinse with Coconut oil pulling

Group Type EXPERIMENTAL

Mouthrinse with Coconut oil pulling

Intervention Type OTHER

Using mouth rinse with coconut oil for two weeks to treat halitosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mouthrinse with Coconut oil pulling

Using mouth rinse with coconut oil for two weeks to treat halitosis

Intervention Type OTHER

Mouthrinse with Chlorhexidine 0.12%

Using mouthrinse with 0.12% chlorhexidine for two weeks to treat halitosis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: Participants must be 18 years or older.
* Diagnosis of Halitosis:

* Clinically diagnosed halitosis with an Organoleptic Test (OT) score ≥ 2, AND
* Volatile sulfur compound (VSC) levels exceeding:

Hydrogen sulfide (H2S) \> 1.5 ng/10 ml, OR Methyl mercaptan (CH3SH) \> 0.5 ng/10 ml.

* Study Population: Buddhist monks and nuns from selected temples in Hue City, Vietnam, to control for dietary and lifestyle factors.
* Willingness to Participate: Participants must provide informed consent and agree to follow the study protocol.

Exclusion Criteria

* Systemic Diseases: Presence of systemic conditions such as diabetes, gastrointestinal disorders, respiratory disorders, or cancer that could contribute to halitosis.
* Nonoral Causes of Halitosis:Halitosis suspected or confirmed to be caused by gastrointestinal or respiratory diseases.
* Medication Use: Use of antibiotics or other medications within 1 month prior to or during the study period.
* Dental Conditions:

* Presence of dental prostheses or orthodontic appliances.
* Untreated open caries lesions or deep periodontal pockets (\> 6 mm).
* Allergies: Known allergies to any of the study interventions (e.g., chlorhexidine or coconut oil).
* Lifestyle Factors: Smoking or betel nut chewing habits.
* Inability to Comply: Inability or unwillingness to follow the study protocol or attend follow-up visits.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hue University of Medicine and Pharmacy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Odonto-Stomatology, Hue University of Medicine and Pharmacy

Huế, , Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Vietnam

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H2023/135

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Flossing With Chlorhexidine
NCT00471783 COMPLETED PHASE3